Energy • Integrated Oil, LNG, Refining & Petrochemicals • SIC 2911
$187.25 ▲ +3.96
(+2.16%)
MKT CAP: $738.90B • VOL: 21.16M
52W L $113 52W H $189
XOM // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-02-18 | FY 2024
FILED 2026-02-18 | FY 2023
FILED 2026-02-18 | FY 2022
FILED 2025-02-19 | FY 2021
FILED 2024-02-28 |
|---|---|---|---|---|---|
| Revenue (Total Sales) | $332.24B | $349.58B | $344.58B | $413.68B | $285.64B |
| YoY Revenue Growth % | -5.0% | +1.4% | -16.7% | +44.8% | +57.4% |
| Gross Profit | — | — | — | — | — |
| Gross Margin % | — | — | — | — | — |
| Research & Development (R&D) | $1.20B | $1.00B | $900.0M | $824.0M | $843.0M |
| Operating Income (EBIT) | $41.27B | $48.87B | $52.78B | $77.75B | $31.23B |
| Operating Margin % | 12.4% | 14.0% | 15.3% | 18.8% | 10.9% |
| Net Income (GAAP) | $28.84B | $33.68B | $36.01B | $55.74B | $23.04B |
| EBITDA (Normalized) | $67.26B | $72.31B | $73.42B | $101.79B | $51.84B |
| Diluted EPS ($/sh) | $6.70 | $7.84 | $8.89 | $13.26 | $5.39 |
| Operating Cash Flow (OCF) | $51.97B | $55.02B | $55.37B | $76.80B | $48.13B |
| Capital Expenditures (CapEx) | $28.36B | $24.31B | $21.92B | $18.41B | $12.08B |
| Free Cash Flow (FCF) | $23.61B | $30.72B | $33.45B | $58.39B | $36.05B |
| FCF Margin % | 7.1% | 8.8% | 9.7% | 14.1% | 12.6% |
| Return on Invested Capital (ROIC %) | 11.3% | 13.7% | 19.4% | 29.8% | 11.9% |
| Cash & Short-Term Equivalents | $10.68B | $23.03B | $31.54B | $29.64B | $6.80B |
| Total Debt (Short + Long Term) | $40.44B | $41.65B | $41.49B | $40.74B | $45.82B |
| Total Stockholders' Equity | $259.39B | $263.70B | $204.80B | $195.05B | $168.58B |
| LINE ITEM (USD / %) | Q1 2026
FILED 2026-05-04 | Q4 2025
FILED 2026-02-18 | Q3 2025
FILED 2025-11-03 | Q2 2025
FILED 2025-08-04 | Q1 2025
FILED 2026-05-04 | Q4 2024
FILED 2026-02-18 |
|---|---|---|---|---|---|---|
| Revenue (Total Sales) | $85.14B | $82.31B | $85.29B | $81.51B | $83.13B | $83.43B |
| YoY Revenue Growth % | +2.4% | -1.3% | -5.3% | -12.4% | +0.1% | -1.1% |
| Gross Profit | — | — | — | — | — | — |
| Gross Margin % | — | — | — | — | — | — |
| Research & Development (R&D) | — | — | — | — | — | — |
| Operating Income (EBIT) | $6.97B | $8.03B | $10.93B | $10.71B | $11.60B | $9.81B |
| Operating Margin % | 8.2% | 9.8% | 12.8% | 13.1% | 13.9% | 11.8% |
| Net Income (GAAP) | $4.18B | $6.50B | $7.55B | $7.08B | $7.71B | $7.61B |
| EBITDA (Normalized) | $13.74B | $8.83B | $17.41B | $16.81B | $17.30B | $10.79B |
| Diluted EPS ($/sh) | $1.00 | $1.54 | $1.76 | $1.64 | $1.76 | $1.72 |
| Operating Cash Flow (OCF) | $8.71B | $12.68B | $14.79B | $11.55B | $12.95B | $12.23B |
| Capital Expenditures (CapEx) | $6.47B | $7.45B | $8.73B | $6.28B | $5.90B | $6.84B |
| Free Cash Flow (FCF) | $2.23B | $5.23B | $6.06B | $5.27B | $7.05B | $5.39B |
| FCF Margin % | 2.6% | 6.3% | 7.1% | 6.5% | 8.5% | 6.5% |
| Return on Invested Capital (ROIC %) | 7.5% | 8.8% | 12.0% | 11.8% | 12.9% | 11.0% |
| Cash & Short-Term Equivalents | $8.44B | $10.68B | $13.81B | $14.35B | $17.04B | $23.03B |
| Total Debt (Short + Long Term) | $47.66B | $40.44B | $42.04B | $38.99B | $37.55B | $41.65B |
| Total Stockholders' Equity | $254.38B | $259.39B | $260.56B | $262.59B | $262.72B | $263.70B |